The vaccine is the first one approved for general use in China.
Chen Shifei, the deputy commissioner of China’s Medical Production Administration, said at a news conference Thursday that the decision had been made the previous night.Please enter your email addressPlease enter a valid email addressPlease enter a valid email addressSIGN UPThe Independent would like to keep you informed about offers, events and updates by email, please tick the box if you would like to be contacted
Read our full mailing list consent terms here
The vaccine is an inactivated, two-dose vaccine from the Beijing Institute of Biological Products, a subsidiary of state-owned conglomerate Sinopharm. The company announced Wednesday that trials had shown it to be 79.3% effective.(Independent)